Clinical Trial

Accelerated High-Dose tDCS for Depression

Recruiting
View on ClinicalTrials.gov →
Summary
In this study, investigators are testing whether a higher dose of a non-invasive brain stimulation technique, called transcranial direct current stimulation (tDCS), can be safely used in people with depression. Participants will come to the Brain Stimulation Lab and receive mild electrical stimulation through electrodes placed on their scalp. The study begins with a safety run-in, where the first few participants will receive stimulation at gradually increasing levels (2, 4, and 6 milliamps) while being closely monitored. If no serious side effects are found, later participants will receive repeated 6 milliamp sessions for 5 days total. Investigators will check skin comfort, mood, and overall tolerability after each session.
Protocol Amendment History 4 changes
notable Primary completion pushed: 2026-06-30 -> 2026-08-30 2026-07-14
minor Completion pushed: 2026-08-01 -> 2026-10-01 2026-07-14
notable Primary completion pushed: 2026-04 -> 2026-06-30 2026-05-13
minor Completion pushed: 2026-06-01 -> 2026-08-01 2026-05-13
Trial Details
NCT Number NCT07226011
Lead Sponsor Medical University of South Carolina
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Major Depression, Major Depression Disorders
Enrollment 20 participants
Start Date 2025-12-15
Primary Completion 2026-08-30 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-13